European equities traded in the US as American depositary receipts were falling on Friday morning, down 1.5% to 1,436.90 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biotech company Genfit (GNFT) and telecommunications company Ericsson (ERIC), which were rising 18% and 1% respectively.
The decliners from continental Europe were led by Danish pharmaceutical giant Novo Nordisk (NVO) and semiconductor manufacturing company STMicroelectronics (STM), which fell 5.9% and 4.4% respectively.
They were followed by semiconductor company ASML (ASML), which declined 3.8%.
From the UK and Ireland, the gainers were led by biotech companies Centessa Pharmaceuticals (CNTA) and Achilles Therapeutics (ACHL), which rose 3.9% and 2.8% respectively.
The decliners from the UK and Ireland were led by Biodexa Pharmaceuticals (BDRX) and Autolus Therapeutics (AUTL), which lost 7.1% and 3.9% respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。